ArticleClinical and experimental medicine2025
Exploring SERTAD4 as a prognostic biomarker and therapeutic target in breast cancer: insights from multidatabase analyses and in vitro studies.
Yuan Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.